<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12737/23736</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-321</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>ЗАВИСИМОСТЬ РЕЗУЛЬТАТА ЛАЗЕРНОГО ЛЕЧЕНИЯ ГИПЕРТРОФИЧЕСКИХ РУБЦОВ ОТ ИСХОДНОЙ РЕАКТИВНОСТИ ОРГАНИЗМА</article-title><trans-title-group xml:lang="en"><trans-title>DEPENDENCE OF OUTCOMES OF HYPERTROPHIC SCARS LASER TREATMENT ON THE INITIAL REACTIVITY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кобец</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kobets</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">kobetsmv@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilyeva</surname><given-names>L. S.</given-names></name></name-alternatives><email xlink:type="simple">lsvirk@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Медицинский центр ЗАО «Эндокринологический центр»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ФГБОУ ВО «Иркутский государственный медицинский университет»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>28</day><month>11</month><year>2016</year></pub-date><volume>1</volume><issue>6</issue><fpage>60</fpage><lpage>65</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кобец М.В., Васильева Л.С., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Кобец М.В., Васильева Л.С.</copyright-holder><copyright-holder xml:lang="en">Kobets M.V., Vasilyeva L.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/321">https://www.actabiomedica.ru/jour/article/view/321</self-uri><abstract><p>Цель - выявление взаимосвязи между реактивностью организма и результатом лечения гипертрофических рубцов. Установлено, что при положительном результате лечения у пациенток был ниже контрольного уровень СТГ (0,5 ± 0,1 мме/мл) и выше - уровни прогестерона (6,0 ± 0,4 нмоль/л) и ФСГ (6,7 ± 0,5 мме/мл); при отрицательном результате выше индекс атерогенности (2,6 ± 0,2) и уровень СТГ (2,1 ± 0,5), ниже - уровни кортизола (346,8 ± 39 нмоль/л), тестостерона (1,5± 0,2мме/мл), lL-10 (3,89 ± 1,6 нг/мл) и антител к lFN-y (0,206 ± 0,05 отн. ед.), lFN-a (0,385 ± 0,02) и Fc-фрагментам (0,317 ± 0,04)</p></abstract><trans-abstract xml:lang="en"><p>The purpose of the study was to identify the relationship between the initial state of the organism and the result of the treatment of hypertrophic scars. 38 women of 16-35years of age were examined on the 5-7th days of the menstrual cycle, 16 of them had normotrophic scars and 22 - hypertrophic scars. The quality of scars, lipid profile, the concentration of thyrotropin, free fraction of thyroxine, growth hormone (GH), luteinizing and follicle stimulating hormone (FSH), cortisol, prolactin, estradiol, testosterone, progesterone, the concentration of TNF-a, lL-4, lL-6, lL-10, and the level of autoantibodies to DNA, lFN-a, lFN-y, b2-glycoprotein, Fc-fragments, collagen-2 were determined. Further on the laser treatment was performed: the scar surface was treated by multiple perforations under local anesthesia. Treatment outcome was assessed in 3 months by the clinical characteristics of the scar. lt was found that in 10 women hypertrophic scars reformed in normotrophic scars after the treatment, and 12 women still had hypertrophic scars. Patients with a positive result of treatment had a low concentration of GH (0.5 ± 0.1) and high concentrations of progesterone (6.0 ± 0.4) and FSH (6.7 ± 0.5 in the follicular phase of the cycle). The negative result of the treatment obtained in patients with significant shifts reactivity indicators: high atherogenic index (2.6 ± 0.2) and the level of GH (2.1 ± 0.5), low levels of cortisol (346.8 ± 39), testosterone (1.5 ± 0.2), lL-10 (3.89 ± 1.6) and antibodies to lFN-y (0.206 ± 0.05), lFN-a (0.385 ± 0.02), Fc-fragments (0.317± 0.04).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лечение гипертрофических рубцов</kwd><kwd>реактивность организма</kwd><kwd>патогенез гипертрофических рубцов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>treatment of hypertrophic scars</kwd><kwd>reactivity</kwd><kwd>pathogenesis of hypertrophic scars</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Поляков Л.М., Суменкова Д.В., Князев Р.А. Анализ взаимодействия липопротеинов и стероидных гормонов // Биомедицинская химия. - 2011. - Т. 57, Вып. 3. - С. 308-313. Polyakov LM, Sumenkova DV, Knyazev RA (2011). Analysis of the interaction of lipoproteins and steroid hormones [Analiz vzaimodeystviya lipoproteinov i steroidnykh gormonov]. Biomeditsinskaya khimiya, 57 (3), 308-313.</mixed-citation><mixed-citation xml:lang="en">Поляков Л.М., Суменкова Д.В., Князев Р.А. Анализ взаимодействия липопротеинов и стероидных гормонов // Биомедицинская химия. - 2011. - Т. 57, Вып. 3. - С. 308-313. Polyakov LM, Sumenkova DV, Knyazev RA (2011). Analysis of the interaction of lipoproteins and steroid hormones [Analiz vzaimodeystviya lipoproteinov i steroidnykh gormonov]. Biomeditsinskaya khimiya, 57 (3), 308-313.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Тенчурина Т.Г. Значение половых стероидов и ангиогенных факторов роста в профилактике осложнений рубцевания после косметических операций // Экспериментальная и клиническая дерматокосметология. - 2005. - № 4. - С. 17-20. Tenchurina TG (2005). Significance of sex steroids and angiogenic growth factors in the prevention of scarring complications after cosmetic surgery [Znachenie polovykh steroidov i angiogennykh faktorov rosta v profilaktike oslozhneniy rubtsevaniya posle kosmeticheskikh operatsiy]. Eksperimental'naya i klinicheskaya dermatokosmetologiya, (4), 17-20.</mixed-citation><mixed-citation xml:lang="en">Тенчурина Т.Г. Значение половых стероидов и ангиогенных факторов роста в профилактике осложнений рубцевания после косметических операций // Экспериментальная и клиническая дерматокосметология. - 2005. - № 4. - С. 17-20. Tenchurina TG (2005). Significance of sex steroids and angiogenic growth factors in the prevention of scarring complications after cosmetic surgery [Znachenie polovykh steroidov i angiogennykh faktorov rosta v profilaktike oslozhneniy rubtsevaniya posle kosmeticheskikh operatsiy]. Eksperimental'naya i klinicheskaya dermatokosmetologiya, (4), 17-20.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шварц Я.Ш. Действие холестерина и агонистов ядерных гормональных рецепторов на продукцию трансформирующего фактора роста-бета в макрофагах // Бюллетень экспериментальной биологии и медицины. - 2009. - № 9. - С. 294-297. Schwartz YS (2009). Effects of cholesterol and nuclear hormone receptor agonists in the production of transforming growth factor-beta in macrophages [Deystvie kholesterina i agonistov yadernykh gormonal’nykh retseptorov na produktsiyu transformiruyushchego faktora rosta-beta v makrofagakh]. Byulleten' eksperimental'noy biologii i meditsiny, (9), 294-297.</mixed-citation><mixed-citation xml:lang="en">Шварц Я.Ш. Действие холестерина и агонистов ядерных гормональных рецепторов на продукцию трансформирующего фактора роста-бета в макрофагах // Бюллетень экспериментальной биологии и медицины. - 2009. - № 9. - С. 294-297. Schwartz YS (2009). Effects of cholesterol and nuclear hormone receptor agonists in the production of transforming growth factor-beta in macrophages [Deystvie kholesterina i agonistov yadernykh gormonal’nykh retseptorov na produktsiyu transformiruyushchego faktora rosta-beta v makrofagakh]. Byulleten' eksperimental'noy biologii i meditsiny, (9), 294-297.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ashcroft GS, Dodsworth J, van Boxtel E (1997). Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med., 3 (11), 1209-1215.</mixed-citation><mixed-citation xml:lang="en">Ashcroft GS, Dodsworth J, van Boxtel E (1997). Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med., 3 (11), 1209-1215.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gilliver SC (2006). Androgens modulate the inflammatory response during acute wound healing. J. Cell Sci., 119 (4), 722-732.</mixed-citation><mixed-citation xml:lang="en">Gilliver SC (2006). Androgens modulate the inflammatory response during acute wound healing. J. Cell Sci., 119 (4), 722-732.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fruchtman S, Simmons JG, Michaylira CZ (2005). Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am. J.Physiol. Gastrointest. Liver Physiol., 289 (2), 342-350.</mixed-citation><mixed-citation xml:lang="en">Fruchtman S, Simmons JG, Michaylira CZ (2005). Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am. J.Physiol. Gastrointest. Liver Physiol., 289 (2), 342-350.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hu ZC, Tang B, Guo D, Zhang J, Liang YY, Ma D, Zhu JY (2014). Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin. Exp. Dermatol, 39 (7), 822-828.</mixed-citation><mixed-citation xml:lang="en">Hu ZC, Tang B, Guo D, Zhang J, Liang YY, Ma D, Zhu JY (2014). Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin. Exp. Dermatol, 39 (7), 822-828.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kanda N, Watanabe S (2005) Regulatory roles of sex hormones in cutaneous biology and immunology. J. Dermatol. Sci., 38 (1), 1-7.</mixed-citation><mixed-citation xml:lang="en">Kanda N, Watanabe S (2005) Regulatory roles of sex hormones in cutaneous biology and immunology. J. Dermatol. Sci., 38 (1), 1-7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Karamouti M, Kollia P, Kallitsaris A, Vamvakopoulos N, Kollios G, Messinis IE (2008) Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil. Steril, 90 (4), 1444-1450.</mixed-citation><mixed-citation xml:lang="en">Karamouti M, Kollia P, Kallitsaris A, Vamvakopoulos N, Kollios G, Messinis IE (2008) Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil. Steril, 90 (4), 1444-1450.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lawrence JW (2012). Epidemiology and impact of scarring after burn injury: a systematic review of the literature. J. Burn. Care Res., 33 (1), 136-146.</mixed-citation><mixed-citation xml:lang="en">Lawrence JW (2012). Epidemiology and impact of scarring after burn injury: a systematic review of the literature. J. Burn. Care Res., 33 (1), 136-146.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt M, Renner C, Löffler G (1998) Progesterone inhibits glucocorticoid-dependent aromatase induction in human adipose fibroblasts. J. Endocrinol., 158 (3), 401-407.</mixed-citation><mixed-citation xml:lang="en">Schmidt M, Renner C, Löffler G (1998) Progesterone inhibits glucocorticoid-dependent aromatase induction in human adipose fibroblasts. J. Endocrinol., 158 (3), 401-407.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Taketani T, Yamagata Y, Takasaki A, Matsuoka A, Tamura H, Sugino N (2008) Effects of growth hormone and insulin-like growth factor 1 on progesterone production in human luteinized granulosa cells. Fertil. Steril., 90 (3), 744-748.</mixed-citation><mixed-citation xml:lang="en">Taketani T, Yamagata Y, Takasaki A, Matsuoka A, Tamura H, Sugino N (2008) Effects of growth hormone and insulin-like growth factor 1 on progesterone production in human luteinized granulosa cells. Fertil. Steril., 90 (3), 744-748.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Van Vugt HH (2008). Somatostatin in the rat periventricular nucleus: sex differences and effect of gonadal steroids. Exp. Brain. Res., 188 (4), 483-491.</mixed-citation><mixed-citation xml:lang="en">Van Vugt HH (2008). Somatostatin in the rat periventricular nucleus: sex differences and effect of gonadal steroids. Exp. Brain. Res., 188 (4), 483-491.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE (2007). Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen., 15 (4), 530-539.</mixed-citation><mixed-citation xml:lang="en">Wang J, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE (2007). Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen., 15 (4), 530-539.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu Z, Ding J, Shankowsky HA, Tredget EE (2013). The molecular mechanism of hypertrophic scar. J. Cell. Commun. Signal., 7 (4), 239-252.</mixed-citation><mixed-citation xml:lang="en">Zhu Z, Ding J, Shankowsky HA, Tredget EE (2013). The molecular mechanism of hypertrophic scar. J. Cell. Commun. Signal., 7 (4), 239-252.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
